BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36939145)

  • 1. The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking.
    Rague JM; Ma M; Dooley G; Wang GS; Friedman K; Henthorn TK; Brooks-Russell A; Kosnett MJ
    Clin Toxicol (Phila); 2023 May; 61(5):363-369. PubMed ID: 36939145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking.
    Kosnett MJ; Ma M; Dooley G; Wang GS; Friedman K; Brown T; Henthorn TK; Brooks-Russell A
    Clin Toxicol (Phila); 2023 May; 61(5):355-362. PubMed ID: 37293900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
    J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.
    Lee D; Vandrey R; Mendu DR; Murray JA; Barnes AJ; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):494-501. PubMed ID: 25220020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of cannabinoids in human cerumen samples by use of UPLC-MS/MS as a potential biomarker for drug use.
    Christodoulou MC; Constantinou MS; Louppis AP; Christou A; Stavrou IJ; Kapnissi-Christodoulou CP
    J Pharm Biomed Anal; 2023 Jul; 231():115412. PubMed ID: 37087774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood and Oral Fluid Cannabinoid Profiles of Frequent and Occasional Cannabis Smokers.
    Hoffman MA; Hubbard JA; Sobolesky PM; Smith BE; Suhandynata RT; Sanford S; Sones EG; Ellis S; Umlauf A; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
    J Anal Toxicol; 2021 Sep; 45(8):851-862. PubMed ID: 34173005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of Recent Cannabis Use in Blood, Oral Fluid and Breath.
    Hubbard JA; Hoffman MA; Ellis SE; Sobolesky PM; Smith BE; Suhandynata RT; Sones EG; Sanford SK; Umlauf A; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
    J Anal Toxicol; 2021 Sep; 45(8):820-828. PubMed ID: 34185831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
    Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detectability of cannabinoids in the serum samples of cannabis users: Indicators of recent cannabis use? A follow-up study.
    Krämer M; Schäper M; Dücker K; Philipsen A; Losacker M; Dreimüller N; Engelmann J; Madea B; Hess C
    Drug Test Anal; 2021 Sep; 13(9):1614-1626. PubMed ID: 34114750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
    Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indeterminacy of cannabis impairment and ∆
    Wurz GT; DeGregorio MW
    Sci Rep; 2022 May; 12(1):8323. PubMed ID: 35585089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulated driving performance among daily and occasional cannabis users.
    Brooks-Russell A; Brown T; Friedman K; Wrobel J; Schwarz J; Dooley G; Ryall KA; Steinhart B; Amioka E; Milavetz G; Sam Wang G; Kosnett MJ
    Accid Anal Prev; 2021 Sep; 160():106326. PubMed ID: 34403895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC.
    Karschner EL; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
    Drug Alcohol Depend; 2012 Oct; 125(3):313-9. PubMed ID: 22464363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
    Kraemer M; Madea B; Hess C
    Drug Test Anal; 2019 Oct; 11(10):1498-1506. PubMed ID: 31407526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use.
    Koch CD; Xu L; Curtis SA; Roberts JD; Bunch DR; El-Khoury JM
    Clin Chim Acta; 2020 Nov; 510():515-521. PubMed ID: 32795544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath.
    Hubbard JA; Smith BE; Sobolesky PM; Kim S; Hoffman MA; Stone J; Huestis MA; Grelotti DJ; Grant I; Marcotte TD; Fitzgerald RL
    Clin Chem Lab Med; 2020 Apr; 58(5):673-681. PubMed ID: 31527291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.